Ortivus AB (publ)

Stockholm Stock Exchange ORTI-B.ST

Ortivus AB (publ) Operating Cash Flow for the year ending December 31, 2023: USD -29.91 K

Ortivus AB (publ) Operating Cash Flow is USD -29.91 K for the year ending December 31, 2023, a 95.45% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Ortivus AB (publ) Operating Cash Flow for the year ending December 31, 2022 was USD -656.85 K, a -176.74% change year over year.
  • Ortivus AB (publ) Operating Cash Flow for the year ending December 31, 2021 was USD 855.92 K, a -62.09% change year over year.
  • Ortivus AB (publ) Operating Cash Flow for the year ending December 31, 2020 was USD 2.26 M, a 704.60% change year over year.
  • Ortivus AB (publ) Operating Cash Flow for the year ending December 31, 2019 was USD -373.46 K, a -550.92% change year over year.
Key data
Date Operating Cash Flow Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: ORTI-B.ST

Ortivus AB (publ)

Description

Ortivus AB (publ) develops and commercializes medical technology solutions for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitors and measures the patient's vital parameters, such as ECG, blood pressure, and SpO2; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed Life, which is designed for advanced monitoring and resuscitation; and MobiMed Cloud that supports multiplatform data sharing on Windows, Webb, IOS, and Android. It also provides support, implementation, training, and consulting services. The company was incorporated in 1985 and is headquartered in Danderyd, Sweden.

Similar companies

MOB.ST

Moberg Pharma AB (publ)

USD 0.85

-1.32%

StockViz Staff

February 5, 2025

Any question? Send us an email